AAT Healthcare Limited 14596851 false 2023-01-17 2024-06-30 2024-06-30 The principal activity of the company is Management activities of holding companies Digita Accounts Production Advanced 6.30.9574.0 true true 14596851 2023-01-17 2024-06-30 14596851 2024-06-30 14596851 bus:Director1 1 2024-06-30 14596851 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2024-06-30 14596851 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 14596851 bus:SmallEntities 2023-01-17 2024-06-30 14596851 bus:AuditExemptWithAccountantsReport 2023-01-17 2024-06-30 14596851 bus:FilletedAccounts 2023-01-17 2024-06-30 14596851 bus:SmallCompaniesRegimeForAccounts 2023-01-17 2024-06-30 14596851 bus:RegisteredOffice 2023-01-17 2024-06-30 14596851 bus:Director1 2023-01-17 2024-06-30 14596851 bus:Director1 1 2023-01-17 2024-06-30 14596851 bus:Director2 2023-01-17 2024-06-30 14596851 bus:PrivateLimitedCompanyLtd 2023-01-17 2024-06-30 14596851 countries:EnglandWales 2023-01-17 2024-06-30 14596851 bus:Director1 1 2023-01-16 iso4217:GBP xbrli:pure

Registration number: 14596851

AAT Healthcare Limited

Unaudited Filleted Financial Statements

for the Period from 17 January 2023 to 30 June 2024

 

AAT Healthcare Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 6

 

AAT Healthcare Limited

Company Information

Directors

A Tejani

Ms T Tejani

Registered office

Suite A4
Skylon Court Coldnose Road
Rotherwas
Hereford
HR2 6JS

Accountants

Boon and Worth Limited
Suite A4, Skylon Court
Coldnose Road
Rotherwas
Hereford
HR2 6JS

 

AAT Healthcare Limited

(Registration number: 14596851)
Balance Sheet as at 30 June 2024

Note

2024
£

Fixed assets

 

Other financial assets

4

96,026

Current assets

 

Cash at bank and in hand

 

21,601

Creditors: Amounts falling due within one year

5

(121,483)

Net current liabilities

 

(99,882)

Net liabilities

 

(3,856)

Capital and reserves

 

Called up share capital

2

Retained earnings

(3,858)

Shareholders' deficit

 

(3,856)

 

AAT Healthcare Limited

(Registration number: 14596851)
Balance Sheet as at 30 June 2024

For the financial period ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 7 October 2024 and signed on its behalf by:
 

.........................................
A Tejani
Director

 

AAT Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 17 January 2023 to 30 June 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Suite A4
Skylon Court Coldnose Road
Rotherwas
Hereford
HR2 6JS
England

These financial statements were authorised for issue by the Board on 7 October 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

AAT Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 17 January 2023 to 30 June 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2.

 

AAT Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 17 January 2023 to 30 June 2024

4

Other financial assets (current and non-current)

Financial assets at cost less impairment
£

Total
£

Non-current financial assets

Cost or valuation

Additions

96,026

96,026

At 30 June 2024

96,026

96,026

Impairment

Carrying amount

At 30 June 2024

96,026

96,026

5

Creditors

Creditors: amounts falling due within one year

2024
£

Due within one year

Accruals and deferred income

1,680

Other creditors

119,803

121,483

6

Related party transactions

Transactions with directors

2024

At 17 January 2023
£

Advances to director
£

Repayments by director
£

At 30 June 2024
£

A Tejani

Director's loan account

-

2

(119,565)

(119,563)